American Association for Cancer Research
Browse
15417786mcr070243-sup-supplementary_figures_s1-s5.pdf (2.55 MB)

Supplementary Figures S1-S5 from Glioma Regression In vitro and In vivo by a Suicide Combined Treatment

Download (2.55 MB)
journal contribution
posted on 2023-04-03, 18:08 authored by Vega García-Escudero, Ricardo Gargini, Marta Izquierdo
Supplementary Figures S1-S5 from Glioma Regression In vitro and In vivo by a Suicide Combined Treatment

History

ARTICLE ABSTRACT

We present here a suicide therapy against malignant gliomas based on the transfer to tumor cells of a gene encoding a β-glucosidase, linamarase (lis), which in the presence of the innocuous substrate linamarin (lin) produces cyanide, blocking the mitochondrial respiratory chain. Dog glioma cells carrying the lis gene are thus sensitive to lin (IC50 of 250 μg/mL at 48 hours) and cell death is accompanied by mitochondrial fission and ATP depletion. The combination of lis/lin with an otherwise nontoxic level of glucose oxidase (GO) enhances the therapeutic potential (IC50 of 50 μg/mL at 48 hours). GO produces hydrogen peroxide, inducing oxidative damage and increasing cellular stress. We show here the antitumoral effect of the lis/lin/GO therapy in a canine glioma cell line and in a xenograft glioma model in nude mice. The synergic combination causes mitochondrial membrane depolarization and phosphatidylserine externalization and accelerates death by 48 hours. The lethal process is caspase independent; poly(ADP-ribose) polymerase 1 is not implicated; and there is no apoptosis-inducing factor translocation to the nucleus. The combined system induces autophagic cell death that can be rescued by 3-methyladenine and is characterized by the presence of double-membrane vesicles and punctate LC-3 pattern. (Mol Cancer Res 2008;6(3):407–17)

Usage metrics

    Molecular Cancer Research

    Categories

    Keywords

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC